See also this year's filing and all EDGAR filings for this company.
PDF Report 0001236997_2016_Counterpath_CORP.pdf
Logs
warning | The stock price does not exist | industry.us_generic | {} |
warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
warning | No stock price available | subcommand.plot | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001236997')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001236997, Counterpath CORP
xvar | xval | |
---|---|---|
0 | LiabilitiesCurrent | 4,245,683 |
1 | LongTermDebt | 0 |
2 | remainder_Liabilities | 58,323 |
3 | IntangibleAssets | 7,311,449 |
4 | AssetsNoncurrent | 216,125 |
5 | AssetsCurrent | 6,326,187 |
6 | PropertyPlantAndEquipmentNet | 271,736 |
7 | remainder_Assets | 97,667 |
8 | SellingAndMarketingExpense | 4,935,671 |
9 | GeneralAndAdministrativeExpense | 4,522,044 |
10 | ResearchAndDevelopmentExpense | 5,669,217 |
11 | remainder_Expenses | 2,223,300 |
12 | remainder_Revenues | 12,003,083 |
13 | remainder_NetIncome | 905,282 |
14 | remainder_ComprehensiveNetIncome | -1,408,044 |
yvar | yval | |
---|---|---|
0 | Liabilities | 4,304,006 |
1 | Assets | 14,223,164 |
2 | Expenses | 17,350,232 |
3 | Revenues | 12,003,083 |
4 | StockholdersEquity | 9,919,158 |
5 | NetIncome | -4,441,867 |
6 | ComprehensiveNetIncome | -5,849,911 |
7 | BaseVar | 25,096,906 |
8 | EconomicCapitalRatiobeforeLimitedLiability | 2.90 |
9 | EconomicCapitalRatio | 4.48 |